Lancet-话题@MedSci

#Lancet#

4376篇内容 | 10435人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1831481, encodeId=de07183148114, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Respir Med：巴利西尼加标准护理治疗有创机械通气或体外膜氧合新冠肺炎危重患者的有效性和安全性, objectType=article, longId=299602, objectId=0054299602f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0054299602f1, replyNumber=0, likeNumber=79, createdTime=2022-11-17, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0054299602f1, moduleTitle=Lancet Respir Med：巴利西尼加标准护理治疗有创机械通气或体外膜氧合新冠肺炎危重患者的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0054299602f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831462, encodeId=29611831462eb, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Haematol：Melflufen联合地塞米松治疗复发性或难治性多发性骨髓瘤, objectType=article, longId=295220, objectId=fab329522003, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fab329522003, replyNumber=0, likeNumber=86, createdTime=2022-12-31, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fab329522003, moduleTitle=Lancet Haematol：Melflufen联合地塞米松治疗复发性或难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fab329522003)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831224, encodeId=7a0d183122438, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Infect Dis：SARS-CoV-2灭活疫苗BBIBP-CorV的安全性和免疫原性 , objectType=article, longId=213334, objectId=6a162133342f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a162133342f, replyNumber=0, likeNumber=86, createdTime=2022-05-14, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a162133342f, moduleTitle=Lancet Infect Dis：SARS-CoV-2灭活疫苗BBIBP-CorV的安全性和免疫原性 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a162133342f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831180, encodeId=b09e18311809e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet：诺和诺德公司IL-6抑制剂对动脉粥样硬化高危患者炎症水平的影响, objectType=article, longId=211681, objectId=cdd721168120, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdd721168120, replyNumber=0, likeNumber=75, createdTime=2021-10-29, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdd721168120, moduleTitle=Lancet：诺和诺德公司IL-6抑制剂对动脉粥样硬化高危患者炎症水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdd721168120)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831141, encodeId=85f518311416a, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet：IL-17A/F纳米体索洛奇单抗治疗斑块型银屑病II期临床获得成功, objectType=article, longId=210523, objectId=496421052350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=496421052350, replyNumber=0, likeNumber=69, createdTime=2021-10-16, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=496421052350, moduleTitle=Lancet：IL-17A/F纳米体索洛奇单抗治疗斑块型银屑病II期临床获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=496421052350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831247, encodeId=8a95183124ee3, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Neurology-系统集中监测房颤，可有利于发现脑缺血事件, objectType=article, longId=214469, objectId=e65b214469ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e65b214469ad, replyNumber=0, likeNumber=76, createdTime=2022-05-11, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e65b214469ad, moduleTitle=Lancet Neurology-系统集中监测房颤，可有利于发现脑缺血事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e65b214469ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831325, encodeId=930c18313257f, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：雷莫芦单抗联合紫杉醇可作为中国晚期胃癌或GEJ腺癌患者的二线治疗！, objectType=article, longId=218209, objectId=f08c2182095b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f08c2182095b, replyNumber=0, likeNumber=91, createdTime=2022-01-21, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f08c2182095b, moduleTitle=Lancet子刊：雷莫芦单抗联合紫杉醇可作为中国晚期胃癌或GEJ腺癌患者的二线治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f08c2182095b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831276, encodeId=1ab118312e6b6, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：以PD-1/PD-L1抑制剂为基础的不同联合方案的不良事件发生情况, objectType=article, longId=215780, objectId=dc30215e8019, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc30215e8019, replyNumber=0, likeNumber=66, createdTime=2021-11-24, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc30215e8019, moduleTitle=Lancet Oncol：以PD-1/PD-L1抑制剂为基础的不同联合方案的不良事件发生情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc30215e8019)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831449, encodeId=7a63183144931, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：吡咯替尼治疗乳腺癌脑转移，患者获益明显, objectType=article, longId=294866, objectId=f9572948661c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9572948661c, replyNumber=0, likeNumber=75, createdTime=2022-04-15, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9572948661c, moduleTitle=Lancet Oncol：吡咯替尼治疗乳腺癌脑转移，患者获益明显, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9572948661c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831191, encodeId=941f1831191d1, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊 | 130万人数据提示：第二大常见癌症，仅需这一步，结局大不同！, objectType=article, longId=212000, objectId=fc9b21200015, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc9b21200015, replyNumber=0, likeNumber=54, createdTime=2021-08-07, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc9b21200015, moduleTitle=Lancet子刊 | 130万人数据提示：第二大常见癌症，仅需这一步，结局大不同！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc9b21200015)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831365, encodeId=6418183136523, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Rheumatology: 抑制IL-1和IL-6影响COVID-19患者抗SARS-CoV-2抗体的中和活性, objectType=article, longId=219599, objectId=a5c321959961, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5c321959961, replyNumber=0, likeNumber=0, createdTime=2022-09-01, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5c321959961, moduleTitle=Lancet Rheumatology: 抑制IL-1和IL-6影响COVID-19患者抗SARS-CoV-2抗体的中和活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5c321959961)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831436, encodeId=6a33183143602, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Neurol：阿尔茨海默病的血液生物标志物：走向临床应用, objectType=article, longId=293764, objectId=c22e293e64a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c22e293e64a7, replyNumber=0, likeNumber=57, createdTime=2022-09-22, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c22e293e64a7, moduleTitle=Lancet Neurol：阿尔茨海默病的血液生物标志物：走向临床应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c22e293e64a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831149, encodeId=249c183114902, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：曲妥珠单抗德鲁替康用于HER2阳性转移性结直肠癌的疗效和安全性, objectType=article, longId=210899, objectId=70f82108996e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70f82108996e, replyNumber=0, likeNumber=53, createdTime=2022-01-23, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70f82108996e, moduleTitle=Lancet Oncol：曲妥珠单抗德鲁替康用于HER2阳性转移性结直肠癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70f82108996e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831338, encodeId=e9841831338be, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet rheumatology:类风湿性关节炎稳定缓解期患者的治疗逐渐减量和停止(RETRO)：一项多中心、随机、对照、开放标签3期试验, objectType=article, longId=219099, objectId=6d25219099a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d25219099a0, replyNumber=0, likeNumber=70, createdTime=2022-01-07, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d25219099a0, moduleTitle=Lancet rheumatology:类风湿性关节炎稳定缓解期患者的治疗逐渐减量和停止(RETRO)：一项多中心、随机、对照、开放标签3期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d25219099a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831158, encodeId=b6b51831158f6, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：伊匹单抗联合抗PD-1疗法显著改善了对抗PD-1耐药的晚期黑色素瘤患者的临床预后, objectType=article, longId=211183, objectId=ec8c211183ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec8c211183ba, replyNumber=0, likeNumber=73, createdTime=2021-07-09, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec8c211183ba, moduleTitle=Lancet Oncol：伊匹单抗联合抗PD-1疗法显著改善了对抗PD-1耐药的晚期黑色素瘤患者的临床预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec8c211183ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831492, encodeId=7117183149283, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：一胖毁所有——只要控制肥胖，就能减少21种常见疾病发生！, objectType=article, longId=300596, objectId=e1183005964f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1183005964f, replyNumber=0, likeNumber=0, createdTime=2022-10-06, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1183005964f, moduleTitle=Lancet子刊：一胖毁所有——只要控制肥胖，就能减少21种常见疾病发生！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1183005964f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831592, encodeId=93f2183159267, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Psychiatry：真假？血浆中脂肪酸浓度居然与精神分裂症有关！, objectType=article, longId=220360, objectId=bdea220360ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdea220360ce, replyNumber=0, likeNumber=78, createdTime=2022-01-05, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdea220360ce, moduleTitle=Lancet Psychiatry：真假？血浆中脂肪酸浓度居然与精神分裂症有关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdea220360ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831509, encodeId=629618315095d, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：常规使用左旋甲状腺素不能提高甲功正常的TPO-Ab阳性的复发性流产女性的活产率, objectType=article, longId=301347, objectId=117230134e0e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=117230134e0e, replyNumber=0, likeNumber=99, createdTime=2022-06-21, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=117230134e0e, moduleTitle=Lancet子刊：常规使用左旋甲状腺素不能提高甲功正常的TPO-Ab阳性的复发性流产女性的活产率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=117230134e0e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831184, encodeId=de5818311846c, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：治疗甲亢突眼还只知道激素？新型药物了解一下！, objectType=article, longId=211900, objectId=630b211900f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=630b211900f3, replyNumber=0, likeNumber=47, createdTime=2021-11-16, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=630b211900f3, moduleTitle=Lancet子刊：治疗甲亢突眼还只知道激素？新型药物了解一下！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=630b211900f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831499, encodeId=cc36183149953, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：体重正常就可以胡吃海喝？少吃10%就能改善心血管和代谢！, objectType=article, longId=300762, objectId=19a7300e6231, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19a7300e6231, replyNumber=0, likeNumber=161, createdTime=2022-05-26, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19a7300e6231, moduleTitle=Lancet子刊：体重正常就可以胡吃海喝？少吃10%就能改善心血管和代谢！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19a7300e6231)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Lancet

2020-05-29

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Respir Med：巴利西尼加标准护理治疗有创机械通气或体外膜氧合新冠肺炎危重患者的有效性和安全性

2022-11-17

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Haematol：Melflufen联合地塞米松治疗复发性或难治性多发性骨髓瘤

2022-12-31

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Infect Dis：SARS-CoV-2灭活疫苗BBIBP-CorV的安全性和免疫原性

2022-05-14

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet：诺和诺德公司IL-6抑制剂对动脉粥样硬化高危患者炎症水平的影响

2021-10-29

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet：IL-17A/F纳米体索洛奇单抗治疗斑块型银屑病II期临床获得成功

2021-10-16

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Neurology-系统集中监测房颤，可有利于发现脑缺血事件

2022-05-11

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：雷莫芦单抗联合紫杉醇可作为中国晚期胃癌或GEJ腺癌患者的二线治疗！

2022-01-21

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：以PD-1/PD-L1抑制剂为基础的不同联合方案的不良事件发生情况

2021-11-24

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：吡咯替尼治疗乳腺癌脑转移，患者获益明显

2022-04-15

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊 | 130万人数据提示：第二大常见癌症，仅需这一步，结局大不同！

2021-08-07

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Rheumatology: 抑制IL-1和IL-6影响COVID-19患者抗SARS-CoV-2抗体的中和活性

2022-09-01

zhouqu_8 (审核中...)

前往app查看评论内容

#Lancet#

Lancet Neurol：阿尔茨海默病的血液生物标志物：走向临床应用

2022-09-22

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：曲妥珠单抗德鲁替康用于HER2阳性转移性结直肠癌的疗效和安全性

2022-01-23

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet rheumatology:类风湿性关节炎稳定缓解期患者的治疗逐渐减量和停止(RETRO)：一项多中心、随机、对照、开放标签3期试验

2022-01-07

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：伊匹单抗联合抗PD-1疗法显著改善了对抗PD-1耐药的晚期黑色素瘤患者的临床预后

2021-07-09

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：一胖毁所有——只要控制肥胖，就能减少21种常见疾病发生！

2022-10-06

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Psychiatry：真假？血浆中脂肪酸浓度居然与精神分裂症有关！

2022-01-05

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：常规使用左旋甲状腺素不能提高甲功正常的TPO-Ab阳性的复发性流产女性的活产率

2022-06-21

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：治疗甲亢突眼还只知道激素？新型药物了解一下！

2021-11-16

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：体重正常就可以胡吃海喝？少吃10%就能改善心血管和代谢！

2022-05-26

科室
- - 订阅+
  - 更多科室
工具
服务